OSFI Updated its Frequently Asked Questions on COVID-19 related regulatory measures

April 14, 2021 – FAQs were originally published on Apr. 16, 2020. Updated regularly to ensure information remains current and reflects new measures.

FAQ Topics
Areas covered in FAQs include capital, payment deferrals, expected credit loss (ECL) capital treatment, disclosure expectations, market risk, leverage ratio, and liquidity. Market requirements, domestic implementation of Basel III, small and medium-sized bank proportionality initiative, covered bonds, and macro stress testing (MST).

April 2021 Updates
Provided clarification related to how long the reduction in sVaR multipliers will be in effect. As per March 16, 2021, OSFI letter to DTIs subject to market risk capital requirements, SVaR multipliers will return to pre-pandemic levels as of May 1, 2021.

For more information, visit www.osfi-bsif.gc.ca.

Discover More Regulatory Insights

Visit the AxiomSL resource center for recent Regulatory Changes for financial institutions, InsideView Blog, and Thought Leadership.

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.